VCEL - CIK 0000887359
Vericel Corp trades as VCEL and has a market capitalization of $1.91 B, making it the #2121 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $276.26M, up 16.5% from the prior year and net income of $16.52M. This page tracks Vericel Corp through 1,674 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Vericel Corp's revenue grew from $54.38M to $276.26M, a compound annual growth rate of 19.8%. Net profit margin expanded from -36.0% to 6.0% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-18 |
| Insider trade | 4 | 2026-05-15 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider trade | 4 | 2026-05-13 |
| Insider sale notice | 144 | 2026-05-11 |
| Insider trade | 4 | 2026-05-08 |
| Insider trade | 4 | 2026-05-08 |
| Insider sale notice | 144 | 2026-05-07 |
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance | Vericel Corporation
Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid | Vericel Corporation
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility | Vericel Corporation
Vericel to Present at Multiple Upcoming Investor Conferences | Vericel Corporation
The largest companies sharing Vericel Corp's SEC industry classification (biological products, (no diagnostic substances)).
Vericel Corp (VCEL) has a market capitalization of $1.91 B as of 2026-06-10, ranking #2121 among US-listed companies.
Vericel Corp reported revenue of $276.26M for fiscal year 2025, an increase of 16.5% year over year.
Yes. Vericel Corp reported net income of $16.52M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.